Cardiac dysfunction in patients with chronic progressive external ophthalmoplegia
- PMID: 9068909
- PMCID: PMC6656238
- DOI: 10.1002/clc.4960200310
Cardiac dysfunction in patients with chronic progressive external ophthalmoplegia
Abstract
Background: Chronic progressive external ophthalmoplegia (CPEO), which includes Kearns-Sayre syndrome, is a mitochondrial disorder with large deletions of mitochondrial DNA. Recently, mtDNA deletions in cardiac muscle cells were thought to be a cause of dilated cardiomyopathy. However, the cardiac involvement in patients with CPEO is generally considered to be limited to the cardiac conduction system.
Hypothesis: The purpose of this study was to evaluate left ventricular function in patients with CPEO.
Methods: We evaluated the cardiac function of five patients with CPEO by means of carotid pulse recording and Doppler echocardiography.
Results: The ratio of the pre-ejection period to ejection time was increased to 0.67 in one patient and to 0.50 in another. Echocardiography showed left ventricular dilatation and diffuse hypokinetic wall motion in both cases. Left ventricular fractional shortening was decreased to 5 and 19%, respectively, and the mean rate of circumferential shortening was decreased to 0.12 and 0.63 circ/s, respectively. One of the two patient died of congestive heart failure 2 months after the study. The Doppler pattern of left ventricular filling in the three remaining patients showed a decrease in the ratio of peak flow velocity in early diastole to that in late diastole, with an increase in deceleration time.
Conclusion: Although cardiac involvement in patients with CPEO is generally considered to be limited to the cardiac conduction system, left ventricular dysfunction may be present and should receive more attention in the management of patients with CPEO.
References
- 
    - Kearns TP, Sayre GP: Retinitis pigmentosa, external ophthalmoplegia and complete heart block. Unusual syndrome with histologic study in one of two cases. Arch Ophthalmol 1958; 60: 280–289. - PubMed
 
- 
    - DiMauro S, Bonilla E, Zeviani M, Nakagawa M, DeVivo DC: Mitochondrial myopathies. Ann Neurol 1985; 17: 521–538. - PubMed
 
- 
    - Moraes CT, DiMauro S, Zeviani M, Lombes A, Shanske S, Miranda AF, Nakase H, Bonilla E, Werneck LC, Servidei S, Nonaka I, Koga Y, Spiro AJ, Brownell AKW, Schmidt B, Schotland DL, Zupanc M, DeVivo DC, Schon EA, Rowland LP: Mitochondrial DNA deletions in progressive external ophthalmoplegia and Kearns‐Sayre syndrome. N Engl J Med 1989; 320: 1293–1299. - PubMed
 
- 
    - DiMauro S, Moraes CT: Mitochondrial encephalomyopathies. Arch Neurol 1993; 50: 1197–1208. - PubMed
 
- 
    - Flier JS, Underhill LH: Mitochondrial DNA and disease. N Engl J Med 1995; 333: 638–644. - PubMed
 
Publication types
MeSH terms
LinkOut - more resources
- Full Text Sources
 
        